Patent details

EP3244878 Title: SOLID ORAL DOSAGE FORMS

Basic Information

Publication number:
EP3244878
PCT Application Number:
US2016012970
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP167087501
PCT Publication Number:
WO2016115082
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SOLID ORAL DOSAGE FORMS
French Title of Invention:
FORMES GALÉNIQUES ORALES SOLIDES
German Title of Invention:
FESTE ORALE DARREICHUNGSFORMEN
SPC Number:

Dates

Filing date:
12/01/2016
Grant date:
10/08/2022
EP Publication Date:
22/11/2017
PCT Publication Date:
21/07/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/08/2022
EP B1 Publication Date:
10/08/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/01/2023
Expiration date:
12/01/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/08/2022
 
 

Name:
Enteris BioPharma, Inc.
Address:
83 Fulton Street, Boonton, NJ 07005, United States (US)

Inventor

1

Name:
VRETTOS, John
Address:
United States (US)

2

Name:
CLAUDIO, Raymundo
Address:
United States (US)

3

Name:
DAGGS, Thomas
Address:
United States (US)

4

Name:
SHIELDS, Paul
Address:
United States (US)

Priority

Priority Number:
201562102263 P
Priority Date:
12/01/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 38/00; A61K 47/10; A61K 47/12; A61K 47/14; A61K 47/18; A61K 9/48; A61K 9/20; A61K 47/50;

Publication

European Patent Bulletin

Issue number:
202232
Publication date:
10/08/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages